title: Synovial chondromatosis of the temporomandibular joint: clinical and immunohistopathological considerations.
abstract: A histopathological study of 30 cases of synovial osteochondromatosis found that the process followed a temporal sequence characterised by three phases: (I) active intrasynovial disease only; (II) transitional lesions with both active intrasynovial proliferation and free loose bodies; and (III) many free osteochondral bodies with no demonstrable intrasynovial disease [J. Bone Joint Surg. 59 (1977) 792]. We present five cases of synovial chondromatosis of the temporpmandibular joint (TMJ) which we studied by immunohistochemical methods of for transforming growth factor beta (TGFbeta) and tenascin.
authors.affiliation: Department of Oral and Maxillofacial Surgery, Wakayama Medical University, Kimiidera 811-1, Wakayama-city, 641-8509 Wakayama, Japan. fujt@wakayama-med.ac.jp
authors.forename: S
authors.initials: S
authors.lastname: Fujita
authors.forename: H
authors.initials: H
authors.lastname: Yoshida
authors.forename: I
authors.initials: I
authors.lastname: Tojyo
authors.forename: T
authors.initials: T
authors.lastname: Wada
authors.forename: K
authors.initials: K
authors.lastname: Murakami
authors.forename: T
authors.initials: T
authors.lastname: Iizuka
mesh_terms: D000328:Adult; D015838:Chondromatosis, Synovial / Q000473:pathology*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D007594:Joint Loose Bodies / Q000473:pathology*; D013705:Temporomandibular Joint Disorders / Q000473:pathology*; D019063:Tenascin / Q000032:analysis; D016212:Transforming Growth Factor beta / Q000032:analysis
chemical_list: D019063:Tenascin; D016212:Transforming Growth Factor beta